Daniel S. Jonas - 04 Mar 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Mar 2022, 15:18:06 UTC
Prior SEC filing
03 Mar 2022
Next SEC filing
04 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sarah M. Oliker for Daniel S. Jonas by Power of Attorney

Key filing fact

Daniel S. Jonas filed Form 4 for CONMED Corp (CNMD) on 08 Mar 2022.

Key facts

  • This page summarizes Daniel S. Jonas's Form 4 filing for CONMED Corp (CNMD).
  • 12 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 08 Mar 2022, 15:18.

Change

  • Previous filing in this sequence was filed on 03 Mar 2022.
  • Current net transaction value: -$1,677,044.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNMD transaction

Common Stock

Options Exercise

Transaction value
$58,283
Shares
+1,390
Change %
+11%
Price
$41.93
Shares after
13,557
Date
04 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Sale

Transaction value
$199,181
Shares
-1,390
Change %
-10%
Price
$143.30
Shares after
12,167
Date
04 Mar 2022
Ownership
Direct
Footnotes
F1
CNMD transaction

Common Stock

Options Exercise

Transaction value
$151,367
Shares
+3,610
Change %
+30%
Price
$41.93
Shares after
15,777
Date
04 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Sale

Transaction value
$514,141
Shares
-3,610
Change %
-23%
Price
$142.42
Shares after
12,167
Date
04 Mar 2022
Ownership
Direct
Footnotes
F2
CNMD transaction

Common Stock

Options Exercise

Transaction value
$335,776
Shares
+5,600
Change %
+46%
Price
$59.96
Shares after
17,767
Date
04 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Sale

Transaction value
$798,000
Shares
-5,600
Change %
-32%
Price
$142.50
Shares after
12,167
Date
04 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Options Exercise

Transaction value
$878,725
Shares
+11,157
Change %
+92%
Price
$78.76
Shares after
23,324
Date
04 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Sale

Transaction value
$1,589,872
Shares
-11,157
Change %
-48%
Price
$142.50
Shares after
12,167
Date
04 Mar 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNMD transaction Derivative

Options To Purchase Common Stock

Options Exercise

Transaction value
$0
Shares
-1,390
Change %
-28%
Price
$0.000000
Shares after
3,610
Date
04 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,390
Exercise price
$41.93
Footnotes
F3
CNMD transaction Derivative

Options To Purchase Common Stock

Options Exercise

Transaction value
$0
Shares
-3,610
Change %
-100%
Price
$0.000000*
Shares after
0
Date
04 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,610
Exercise price
$41.93
Footnotes
F3
CNMD transaction Derivative

Options To Purchase Common Stock

Options Exercise

Transaction value
$0
Shares
-5,600
Change %
-51%
Price
$0.000000
Shares after
5,400
Date
04 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,600
Exercise price
$59.96
Footnotes
F3
CNMD transaction Derivative

Options To Purchase Common Stock

Options Exercise

Transaction value
$0
Shares
-11,157
Change %
-53%
Price
$0.000000
Shares after
10,000
Date
04 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,157
Exercise price
$78.76
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.28 to $143.34. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.40 to $142.54. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

Footnote F3

The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Footnote F4

The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .